| Accession Number: | 0000899243-21-026534 |
| Date: | 2021-06-25 |
| Issuer: | T2 BIOSYSTEMS, INC. (TTOO) |
| Original Submission Date: |
LIEBMAN SEYMOUR
101 HARTWELL AVENUE
LEXINGTON, MA 02421
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2021-06-25 | M | 45,454 | a | $0.00 | 129,639 | direct |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RESTRICTED STOCK UNITS | 0.0 | 2021-06-25 | deemed execution date | M | 45,454 (d) | common stock 45,454 | $0.00 | 45,454 | direct | |||
| RESTRICTED STOCK UNITS | 0.0 | 2021-06-25 | deemed execution date | A | 73,224 (a) | common stock 73,224 | $0.00 | 73,224 | direct |
| ID | footnote |
|---|---|
| f1 | each restricted stock unit represents a contingent right to receive one share of issuer's common stock. |
| f2 | on august 6, 2020 the reporting person was granted 45,454 restricted stock units that vested on june 25, 2021. |
| f3 | the restricted stock units vest in one installment on the earlier of (i) june 25, 2022 and (ii) the date of the next annual meeting of stockholders. |
